Clinical Trial Update: A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating NN1250 at steady state in adults with Type 1 diabetes mellitus has completed, reporting results from the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED